This market can only focus on one bullish idea at a time. And it just feeds Everything Else to the hungry bears. Today the market decided that oil is going to the moon, because it did show a huge draw down. Actually, to be fair to the oil traders, it took crude up nearly 2, a reduction of 4. 5 million barrels. Its the second biggest in this reduction is amazing. No one saw it coming. Weve heard over and over and over again that theres way too much oil, so theres a gigantic glut. Every now and then, some combination of countries had decided that oils fallen enough. You hear chatter about an takes it from the low 40s to the high 40s. Before a new flood of american oil hits the market. Those past rallies were all big con jobs. But Oil Inventories are not a con job. This number tells us that the reports that theres no more room to store oil may be greatly exaggerated. Reports that were overrun with imports may nt be possible. What happens . The whole oil complex goes completely nutty as is always the case when the price of oil spikes, the winner is chesapeake, which rocketed up nearly 13 . It is one of the most troubled properties to get ahead in the game. When you get a spike, thats a sign that you dont have to worry about chesapeake. Can you take their viability issues off the table. And thats something thats gone on ever since it traded down at 1. 50. While i like the firefighter style management at chesapeake, im not a fan of the stock because the Balance Sheet still is hideous. Performer in the group that makes me cringe, that was in todays action. Im talking about really bugging me, because it represents a huge extrapolation off a single piece of data. Im talking about Diamond Offshore drilling. It was up nearly 9 today. Heres a company that spoke tuesday, yes, literally two days is awful. Why . Because diamonds business is offshore, not on land. But offshore of they told you that offshore drilling doesnt get profitable for Oil Companies until crude hits 60 a barrel. Its antithetical to have rational thought. We have the usual suspects. The murphy, southwestern, marathon. And then we get to apach now when i got into this racket back in the early 80s, there was a canadian stock, a genuine rocket ship. Its one of the greatest runs ive ever seen but it ended badly in an avalanche of debt. Spots of oil, alpine, they call it where it secured 300,000 acres of land which might have as much as 3 billion barrels, it is a gigantic find and has been kept very much under wraps. We were told it was one of the biggest finds of oil that could be announced sim apache has rallied, understandable that the company was only worth 20 billion before the news broke. And its up 14 . Heres the rub. Like dome petroleum, we cant prove what apache has. We cant just say certified by core labs. This is an area that oil geologists told us for many years wasnt worth fracking about. It will be a while before we know whether this find will be this big. Nevertheless, thanks to the big Oil Inventory draw down and the fact that the market today only has eyes for oil, apache stock gets the benefit of the doubt and roars and roars, which brings me to the problem with this kind of action. The markets onetrack mind doesnt just favor one group like the oils. Lots of companies and sectors are laying down on the track so to speak in order to facilitate the smooth train ride for the oils. Take apple. Heres a company that unveiled an any phone yesterday which i think is manna from heaven for millennials. It has longer battery life, so necessary when youre looking for pokemon go. But i think the real reason its down is it decided its no longer going to announce the weekend sales it amasses for the iphone 7. Thats something we got used to when the first phone got rolled out. Despite management making it clear that this is a supply issue and the phone is already sold out by this weekend, so it would just seem like a lot of hype to announce that, the market reacted hideously the moment reuters broke the news. I think apples reasoning is sound. Apples no longer retailed solely through apple. In its deal with at t. Lots of resalers, its creating a false sense of optimism by waiting till monday and saying hey, its sold out. The markets made up its mind, end of story. The markets also decided its the end of the world for retail. Putting to the a tale of weak numbers from pier one and tractor supply. So what that pier ones collection of faux wicker and dishtowels. Its all about pin action, people as in sell everything retail. Because nobodys buying anything at pier one and tractor supply. So heres the bottom line. When you have the market that decides one thing, only one things working, and it doesnt bother with anything else, then you have a market thats a lot more treacherous than the average scene, and thats whats happening. And if you dont see it, just ask yourself, is it possible that oil which has fooled us so about to jump 10 points to move up 10 . Is it possible that the consumers totally tapped out and not shopping anymore . Or is it more likely that this markets onetrack mind has made the action for the moment totally irrational. Rick in missouri. Rick. Caller i wanted to ask you about petrobras. If they didnt have a debt of 130 billion. That coupled with the spn deal rejection, how can any analyst that says that bbe anything but misleading . Its been very strong. I do agree its a stretched situation, they should be selling stock over fist to raise cash. It was able to rally and continues to do so even though you and i think it shouldnt. Pt in california. Are you doing . Im doing well, how about you . Consider im great. Great job taking mark sanchez last night in your fantasy draft. True, so true next caller. Just kidding, just kidding. Go ahead, rick. Caller we explored that the consumers shopping for furniture online, and i still think they are, but theyre doing that at a place thats much more than dog hair diaper bags, what do you think about etsy, etsy . They went on kellys show. Etsy had a good quarter. I like how theyre doing. Dont bet against Gary Freedman stock and furniture is a gutsy place to be in, but i think etsys real food. The blinders are out on wall street. The markets onetrack mind has winners, and losers like apple. A market thats made up its mind can be more than stubborn. It can be down right, lets say tricky. On mad money tonight, a biotech working to give sight to the blind. Spark therapeutics. Then the most Vulnerable Group out there at this time might surprise you. What sector you should approach with maximum caution. And what do lebron james and Maria Shriver have in common . Theyre investors in the next pizza chain. Stick with cramer. Dont miss a second of mad have a question . Tweet cramer at mad tweets. Send jim an email at madmoney. Cnbc. Com. Or give us a call at 1800743cnbc. Miss something . Head to madmoney. Cnbc. Com. I asked my dentist if an electric toothbrush was going to clean better than a manual. He said sure. But dont get just any one. Get one inspired by dentists, with a round brush head. Go pro with oralb. Oralbs rounded brush head cups your teeth to break up plaque and rotates to sweep it away. And oralb delivers a clinically proven superior clean versus sonicare diamondclean. My mouth feels super clean you can finally break up with bleach. Lysol with hydrogen peroxide. For a tough clean with zero percent bleach. I absolutely love my new york apartment, but the rent is outrageous. Good thing geico offers affordable renters insurance. With great coverage it protects my personal belongings should they get damaged, stolen or destroyed. [doorbell] uh, excuse me. Delivery. Hey. Lo mein, szechwan chicken, chopsticks, soy sauce and you got some fortune cookies. Have a good one. With renters insurance. Wi 80 of recurrent ischemic strokes could be prevented. And im doing all i can to help prevent another one. A bayer aspirin regimen is one of those steps in helping prevent another stroke. Be sure to talk to your doctor before you begin an aspirin regimen. . . I dont think thats how theyre made. This has been an ugly year for biotech, what can i say, as drug prices have been thrown back into the president ial campaign with the latest epipen price hike. It doesnt mean every single biostock is in the doghouse. Far from it. Some of them have continued to be excellent outperformers despite the environment. Take Spark Therapeutics, once, a company that was created in 2013 to have the rights of some programs in childrens hospital. Spark is now developing in the developmental stage in gene therapy. Now the idea here is that once is developing onetime gene they have latestage trials that can help a group of disorders that can cause blindness. And investors have gotten excited about hemophilia therapies. They now have enough cash to keep running for years, more gene therapies onto the market. Plus, if you bought on that secondary, a 30 gain in less than three months. Lets check in with the ceo of Spark Therapeutics and find out about his company and how its doing. How are you . Im reading a philadelphia youre far along on this. We are. Last year we completed successfully a face clinical trials, the first ever pivotal trial in a genetic disease, and that is a significant milestone, and we are now busy near substantial completion of the first marketing authorization weve put to the fda. You did say that literally it brings back sight. This is one of the unique things of what were doing, specifically in gene therapy but spark in particular. What weve seen in these kids and adults that have been in our trial, 93 of them have had a Response Rate as measured by our primary point. This is improving aspects of sight. And were doing that as you said were seeing longtime benefits. This summer we published data in the lancet showing that it was durable. The illness youre talking about is not hundreds and thousands of people. Its a smaller sample that actually have this. Thats right. It is an ultrarare condition. The way weve set up the company as youve said is were focussing on applying gene therapies to the retina, the liver and the Central Nervous system. And the goal at a high level was to prove out the principle with a first application. Weve done that with the eye and the eye with the phase three results in this form of blindness caused by rp e363. Now we speak to a company that comes all the time. And theyve got something very special for hemophilia, are there enough forms that theres still room for spark, or is that just a competitor . In fact, the data weve released this summer is about hemophilia b. Were also working with hemophilia a and expect to start a trial later this year, in the Fourth Quarter of this year. One of the things weve seen in our early data, which is differentiated, were seeing highly consistent results across the subjects. All four of the subjects that we disclosed data on had a robust response, so much so that weve effectively eliminated the need for infuses for these people. 100 infusions would have happened historically for these people, theyve effectively eliminated it. Weve seen consistency, weve the dose is anywhere from 40 to 120fold lower than some of the other doses that have been used in other gene therapy trials. One of the things the countrys gripped by, obviously, is pricing. Take gilead. Gilead like you, its a cure, basically for hep c. But in a populous uprising numbers are turning people off. You obviously cant develop a drug for a small subset and make 500 off of it. What do we do, what do we do in the great ethos debate about pricing for something that brings back sight but costs your company a fortune to develop . I appreciate the question. First of all, its obvious for us to talk about specific price therapy. But i will say what were seeing here has the potential to change most if not everything about the way we think about reimbursement and paying for these therapies. If you take a step back again, we think were developing something that has not been seen before. Were both gaining function in these patients and doing it with a potential onetime treatment that has longlasting benefits. So we as a company are intending to come with solutions and ideas where were saying, lets think differently about the way we contemplate paying for. It might sharing in the risk or the upside. If we see benefits lasting for a very long period of time, how do we get the reward for that . I think we need to come with innovative ideas, and this is the right time to do that, and we intend to lead that at spark. Childrens hospital of philadelphia, the big winner here, and they still have a lot of stock and doing secondaries. I know you dont control what they want to do. But theoretically, the stocks up big. Its not their job to own i know they have a bunch of other investments. Its not their job to own stock. Is that okay . At a high level, theyve been incredibly supportive. Weve done something unique in the way weve formed this company with them. They invested in our initial public offering, and i think its only wise, i cant speak for them, but i think from my perspective, its a fair thing for them to diversify. Theyve been incredibly supportive and are the reason frankly that were are sitting here with the success weve had as a company. Just so you now, those of us from philadelphia are so proud of that institution. Its among the best in the world. Thats jeff rosin. The ceo of Spark Therapeutics. A big winner and deserves to be. Coming up, pizza, and this on the roster who is taking his job to the next level. We got spicy sauce. Cramer goes off the tape when mad money returns. Lets feed him to the sharks squuuuack, lets feed him to the sharks yay and take all of his gold and take all of his gold ya and hide it from the crew ya. . Squuuuack, theyre all morons anyway i never said that. I smell bad if youre a parrot, you repeat things. Its what you do. If you want to save fifteen percent or more on car insurance, you switch to geico. Its what you do. Squuuuack, its what you do. I love my shop, but my back pain was making it hard to sleep and open up on time. Then i found aleve pm. The only one to combine a sleep aid plus the 12 hour pain relieving strength of aleve. Now im back. Aleve pm for a better am. Now, were going to show you how degree dry spray is different. Degree dry spray. Degree. It wont let you down. . . when you are suffering from chest congestion but you have got a full day ahead of you, try mucinex 12hour. Only mucinex has a unique bilayer tablet. The white layer releases immediately. Mucinex is absorbed 60 percent faster than store brands. Wow, the socalled safety stocks have suddenly become real dangerous. From General Mills yesterday. Just a chilling series of words about a missed quarter that only a month ago looked like it was in the bag. Its not often that you see a stock like General Mills drop 3 in a single session as it did. This is a highquality corporation that usually has a good handle on its own destiny. Maybe one of the best handles. Its been a steady as she goes rally machine for ages, but it competition in the crucial yogurt business is a reminder of how doggie dog anything sold in the supermarket is right now, whether it be natural or organic or fresh, its all a big battle ground. Get me . Whos disrupting these things . No names were actually mentioned by the coo. But it looks like theyre taking no prisoners. White wave, a Natural Organic player. I was wondering when the pressure of the supermarket business would trickle down to the Consumer Price stock goods. These former bottom market equivalents, even at customers, the supermarkets keep getting witness how yesterdays bout from sprouts farmers market. It was only a matter of time before the food stocks got taken to the cleaners. Technically after the startling decline of campbells soup. Campbells had previously been among the best performers of the group. But now its down ten points. Thats a huge decline for a food play. The stocks had run so much that its dividend yield had become very puny and offers very little in the way of protection. Its not just campbells soup and General Mills. Theyre not slug companies. Both of them moved aggressively into the natural and organic space, but guess what, so have the private label guys, notably treehouse, with cheaper storebranded merchandise. You can bet when the issue of it, too, was hurt by private label, because it hasnt spent enough time defending its brands. Too little inventory and too little shelf pace hit the distributor. How bad is it for the food place . This category for jm smucker. Previously one of the strongest parts of the supermarket. It was a sucker punch for certain. Theyre trying to make as much as they can by pitting suppliers against each other, and theres been unprecedented food price deflation. Targets hurting. It doesnt want to lose share to walmart, while the Dollar Stores are trying to underbid walmart. Ouch. Caught in the same vice. Is a black hole that investors are just waking up to. If you own any of these stocks, whether it be kelloggs or conagra or clorox, you need to keep one finger on the trigger. We sold two core positions in my heinz and, oh, my, procter and gamble. We feared the future of both companies. The production of principle costs too much. Heres the bottom line. The safety group may prove to be the most vulnerable out there at the moment until the stocks come down where their yields offer more support and the takeover chatter ends. Only then will it be safe to and the stock market as a whole. Don in ohio. Caller i own some pepsi stock. Its been hanging around the low 100s for a time now. Im wondering if theres any upside left. Yeah, i think there is, we sold some, were looking to buy it back if it gets to 100, 102. It is the strongest stock in the food group. I know they get into everything, but thats an opportunity when it comes to pepsico. How about holly in oregon. Caller jim, whoohoo. Costco has lost its mojo. Homogenized offerings. Or what do you think of costco . I think youre too negative on costco. We sold some in the high 60s. They fixed that credit card issue, and the stocks come all the way down. The target price to buy is 150, and i think were going to get there. I love the costco model. I think people have got and little too negative about costco. Dont give up the costco ship. How about olga in oh caller hello, jim. You are my favorite fantastic show. Hanes celestial, is it a dead stock . Yes, in the end, it has uncanny irregularities. Every inch nortel, i have said accounting irregularities equals sell from the high valuations, id